AzTrials
AzTrials

Traumatic Brain Injury (TBI) PatientsNCT07606300

Effect of Fixation Training With Colored Light Targets on Traumatic Brain Injury-Associated Photophobia

A study testing Fixation training using different colored fixation targets in people with Traumatic Brain Injury (TBI) Patients, run by Ohio State University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Many people develop intolerance to light after a head injury, leading to ambient light levels causing discomfort. We do not fully understand why this occurs and how it should be treated. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Traumatic Brain Injury (TBI) Patients
What is being tested?
Fixation training using different colored fixation targets
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
Jan 2005to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 to 80 years old and subjects able to consent for themselves
  • Completion of first session in entirety (participants who cannot complete the entire first visit will be considered as a screen fail)
  • Best-corrected visual acuity of at least 20/32 in both the right and left eyes, and 20/25 using both eyes
  • Prior head injury with current photophobia - A mild or moderate TBI occurring at least 3 months prior to visit, verified by a score of 2, 3 or 4 on OSU-TBI survey, and participant reports having experienced greater light sensitivity since their head injury

Who cannot join

  • Pregnancy or suspected pregnancy - based on self-report
  • Previous history of neurodegenerative disease (e.g. Alzheimer's, Parkinson's, multiple sclerosis, myasthenia gravis, seizures)
  • History of pathology of the retina and optic nerve (includes retinal tears, diabetic retinopathy, glaucoma, macular degeneration, optic nerve atrophy)
  • Currently on cholinergic medications, which affect pupil responses
  • Prior participation in fixation training sessions within the past 2 years
  • Experiencing a migraine during visit
  • Prior history of severe TBI (score of 5 or 6 on OSU-TBI survey)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Andrew Hartwick, OD, PhD contact

16146888308

HARTWICK.4@osu.edu

United States1 site, 1 recruiting
  • College of Optometry

    Columbus, Ohio, 43210

    Andrew Hartwick, OD, PhD, 614-688-8308, HARTWICK.4@osu.edu

    Recruiting

Other trials in United States

About this study

Many people develop intolerance to light after a head injury, leading to ambient light levels causing discomfort. We do not fully understand why this occurs and how it should be treated. A growing number of clinicians have reported improvement in TBI related symptoms reported by patients that undergo daily fixation training with a dim light target. While fixation training using various colored light targets is reported, blue light targets specifically appear to be used in this patient population more often than other light target colors. However, the effectiveness of this approach has yet to be assessed in a well-controlled clinical study. In this work, we will recruit individuals who had a recent brain injury and developed increased light sensitivity. Participants will be divided into two groups: one that first uses daily 20 minute sessions for 12 weeks with the at-home fixation device set to display a blue light target; and another that will undergo similar sessions for 12 weeks using a red light target. Every 6 weeks, masked examiners will measure how well participants can read letters on an eye chart, record pupil responses to light, measure the side vision, measure eye alignment and focusing ability when viewing a near target, and collect information about participants' symptoms. In a cross-over study design, the participants will then switch to sessions involving the other colored fixation light target for another 12 weeks, with data being again collected every 6 weeks. Potential differences in pupil responses to light between the treatment groups will be assessed as an objective outcome measure and compared to subjective symptom survey information. Thus, this work will test the hypothesis that daily fixation training using a blue light target can alleviate light intolerance in participants after head injury more than fixation training with a red light target, and this improvement is associated with altered pupil responses to light. As a significant minority of eye care clinicians currently utilize this approach in this population of patients, this study has the potential to influence clinical practice patterns whether the fixation training is shown to be effective or not.

Read the detailed description

A growing number of clinicians are regularly using fixation training, in which patients undergo daily sessions fixating on colored light targets on light boxes, to treat symptoms including photophobia associated with traumatic brain injury (TBI). While fixation training using various colored light targets is reported, blue light targets specifically appear to be used in this patient population more often than other light target colors. The College of Syntonic Optometry (www.csovision.org) estimates that there are roughly 500 practicing optometrists that utilize fixation training in the USA alone. However, evidence supporting this approach is primarily anecdotal, and there are no controlled, masked clinical trials published that evaluate the efficacy of this therapy against a control group.

Therefore, the goal of this study is to assess whether daily 20 min fixation training sessions using a blue light target alleviates symptoms of light sensitivity and alters pupil response more than daily 20 min fixation training sessions using red light targets in a masked cross-over clinical trial involving participants with chronic TBI-associated photophobia. In addition, we will determine if any improvement in symptomology correlates to any changes in pupil responses to red, blue and white light pulses and potential changes in other standard clinical measures of visual function. In short, this study will compare the effect of fixation training using a blue light target to the effect of fixation training using a red light target in participants with chronic TBI-associated photophobia.

Being tested
Fixation training using different colored fixation targets
Keywords
traumatic brain injury, concussion, photophobia
Medical subject headings
Brain Injuries, Traumatic, Brain Concussion, Photophobia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fixation training using different colored fixation targetsBehavioural

    Red versus blue targets in light boxes used for fixation training

Study groups in NCT07606300
Study groupRoleWhat they receive
Red light first, blue light secondExperimentalRed light first, blue light second for the colored target used in the fixation training
Receives: Behavioral: Fixation training using different colored fixation targets
Blue light first, red light secondExperimentalBlue light first, red light second for the colored target used in the fixation training
Receives: Behavioral: Fixation training using different colored fixation targets

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pupil Responses

    Pupil responses to red, blue and white light stimuli

    Measured: From baseline visit to the end of 3 months of fixation training with each light color

Secondary outcomes (5)
  1. Symptom Survey

    Symptom survey

    Measured: From baseline visit to the end of 3 months of fixation training with each light color

  2. Vergence facility

    Measurement of vergence range (how well eyes work together) with loose prisms

    Measured: From baseline visit to the end of 3 months of fixation training with each light color

  3. Stereopsis

    Measurement of local stereopsis (depth perception) with Randot test

    Measured: From baseline visit to the end of 3 months of fixation training with each light color

  4. Phoria magnitude

    Measure of phorias (how well eyes are aligned) using cover test and loose prisms

    Measured: From baseline visit to the end of 3 months of fixation training with each light color

  5. Near Point of Convergence

    Measure of ability for eyes to converge (how well eyes turn in when reading up close)

    Measured: From baseline visit to the end of 3 months of fixation training with each light color

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 May 2026
  2. Study startJan 2005
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Participants will start with one color of light (either red or blue) for the fixation light and switch to the other light halfway through study.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07606300
Sponsor's protocol ID
2023H0291
Status last verified
May 2026
First submitted
12 May 2026
Last updated
26 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Fixation training using different colored fixation targets in people with Traumatic Brain Injury (TBI) Patients, run by Ohio State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Andrew Hartwick, OD, PhD (16146888308, HARTWICK.4@osu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pupil Responses (time frame: From baseline visit to the end of 3 months of fixation training with each light color). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in